2014 annual financial data
Regeneron Pharmaceuticals 2014 Net income growth
Direct answer
Net income growth was -17.98%.
Operating income was 838,431,000 USD and net income was 348,074,000 USD.
Operating cash flow was 752,435,000 USD.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,819,557,000 USD
- Operating income
- 838,431,000 USD
- Net income
- 348,074,000 USD
- Operating cash flow
- 752,435,000 USD